Bull case
The bull case requires both strong earnings delivery and the market pricing CORZ more generously than it does today.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where CORZ stock could go
The bull case requires both strong earnings delivery and the market pricing CORZ more generously than it does today.
The base case reflects analyst consensus expectations — steady delivery without requiring a major catalyst or re-rating.
The bear case reflects a scenario where earnings shortfalls or multiple compression combine to materially reduce the stock from its current level.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Core Scientific operates large-scale Bitcoin mining facilities and provides colocation hosting services for other miners. It generates revenue primarily from mining Bitcoin for its own account—earning block rewards and transaction fees—and from hosting fees paid by third-party miners who use its infrastructure. The company's competitive advantage lies in its scale, operational expertise, and strategic partnerships with major hardware manufacturers, which provide access to efficient mining equipment.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $-0.04/$-0.07 | +42.9% | $79M/$111M | -29.4% |
| Q4 2025 | $-0.46/$-0.07 | -558.9% | $81M/$112M | -27.6% |
| Q1 2026 | $-0.29/$-0.27 | -7.4% | $80M/$119M | -33.0% |
| Q2 2026 | $-0.10/$-0.02 | -400.0% | $115M/$117M | -1.5% |
CORZ beat EPS estimates in 1 of 4 tracked quarters. Mixed delivery makes the upcoming report a key data point for re-rating.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Benchmark comparison across market, sector, and history below.
| Metric | CORZ | S&P 500 | Technology | 5Y Avg CORZ |
|---|---|---|---|---|
| Forward PE | — | 18.8x | 22.3x | — |
| Trailing PE | -33.1x | 24.4x-236% | 29.0x-214% | — |
| PEG Ratio | — | 1.66x | 1.51x | — |
| EV/EBITDA | — | 15.2x | 16.6x | 39.2x |
| Price/FCF | — | 20.7x | 19.2x | — |
| Price/Sales | 29.1x | 3.1x+840% | 2.4x+1092% | 10.8x+170% |
| Dividend Yield | — | 1.91% | 1.11% | — |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolKey financial metrics for CORZ are shown below.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
Converting mining facilities into Tier-3 data centers for AI requires significant capital investment, posing financial strain.
The business model is highly execution-sensitive, with potential delays or cost overruns impacting growth targets.
Bears argue that rapid growth through power and expansion investments may not be sustainable long-term.
Deep dives into fundamental analysis highlight potential vulnerabilities in Core Scientific's financial stability.
Analyst consensus shows mixed sentiment, with some recommending Strong Buy while others express bearish views.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Core Scientific's forward P/E ratio of 29.15 and forward PS ratio of 8.20 suggest it is fairly valued compared to historical averages, with a fair price range estimated between $15.81 to $28.27.
Core Scientific is repurposing its Pecos, Texas site into a 1.5 gigawatt AI-focused data center campus, supported by a $3.30 billion notes offering, signaling strong growth in AI infrastructure.
Expanded institutional interest and long-term AI infrastructure partnerships highlight Core Scientific's potential as a key player in the AI and data center space.
The completion of a $3.30 billion senior secured notes offering demonstrates Core Scientific's ability to secure significant funding for future growth initiatives.
Core Scientific's share price has shown upward momentum, trading at $18.09 with a recent change of 2.86%, indicating investor confidence in its growth prospects.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
COR CORZ Core Scientific, Inc. | $9.3B | — | +12.4% | -342.9% | Buy | +12.7% |
RIO RIOT Riot Platforms, Inc. | $10.7B | — | +10.4% | -132.8% | Buy | -3.0% |
MAR MARA Marathon Digital Holdings, Inc. | $5.4B | — | +12.4% | -234.8% | Buy | -12.1% |
CLS CLSK CleanSpark, Inc. | $4.4B | — | +13.9% | -67.7% | Buy | +9.6% |
CIF CIFR Cipher Mining Inc. | $11.8B | — | +19.8% | -513.0% | Buy | +9.3% |
BTB BTBT Bit Digital, Inc. | $707M | — | +1.2% | -146.0% | Buy | +176.5% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
Common questions answered from live analyst data and company financials.
Core Scientific, Inc. (CORZ) is rated Buy by Wall Street analysts as of 2026. Of 22 analysts covering the stock, 19 rate it Buy or Strong Buy, 3 rate it Hold, and 0 rate it Sell or Strong Sell. The consensus 12-month price target is $33, implying +12.7% from the current price of $29.
The Wall Street consensus price target for CORZ is $33 based on 22 analyst estimates. The high-end target is $40 (+37.2% from today), and the low-end target is $29 (-0.5%).
Forward earnings data for CORZ is not currently available. Review the valuation table above for trailing P/E, EV/EBITDA, and price-to-sales comparisons against market and sector benchmarks.
The primary risks for CORZ in 2026 are: (1) Capital-intensive expansion — Converting mining facilities into Tier-3 data centers for AI requires significant capital investment, posing financial strain. (2) Execution risk — The business model is highly execution-sensitive, with potential delays or cost overruns impacting growth targets. (3) Growth sustainability — Bears argue that rapid growth through power and expansion investments may not be sustainable long-term. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates CORZ will report consensus revenue of $399M (+12.4% year-over-year) and EPS of $-0.29 (+92.3% year-over-year) for the upcoming fiscal year. The following year, analysts project $447M in revenue.
Core Scientific, Inc. is expected to report its next earnings on approximately 2026-08-14. Consensus expects EPS of $-0.02 and revenue of $145M. Over recent quarters, CORZ has beaten EPS estimates 50% of the time.
Core Scientific, Inc. (CORZ) had a free cash outflow of $471M in free cash flow over the trailing twelve months — a free cash flow margin of 132.8%. CORZ returns capital to shareholders through and share repurchases ($0 TTM).